chariskalogirou

Apply now, spread the word: three (3) fully funded Helmholtz research groups (assistant prof level) with attractive packages. Topics: RNA-based medicine, microbial RNA, and RNA-based infection research incl. RNA technologies. Great environment for young people. Come and join us.

Congratulations to Pailin Pongratanakul for winning the 1st Hans Flohr award with our ‚growing teratoma‘-study at this year’s C. E. Alken conference in Frankfurt a. M…. 🍾🏆💪🏻 @UniklinikDUS @MedHHU @HHU_de @DGUrologie

If you ever wondered how advanced urothelial carcinoma evolves during metastatic spread 👉 Read our review about #bladder cancer #metastsis and #evolution in @NatRevUrol ! Thanks for highlighting @brookmans76 @niklas_kluemper @imedverse @urotoday @OncoAlert

Nice summary of where we are with the DRE. Academic urologists--do you still ask your team to include with their H&P? Is Era of the Digital Rectal Examination (DRE) for Prostate ... : JU Open Plus journals.lww.com/juop/fulltext/…

1/5 Big news from Aguilar Lab! Check out our first preprint! We’ve developed a new prostate organoid model to crack the mystery of E. coli prostatitis, a common, tough-to-treat infection in men. Our model reveals how these bacteria get in and thrive. #UPEC #Organoids #UTI

Special thanks to the Single Cell Center Würzburg @SCC_Wurzburg, @AE_Saliba, and @chariskalogirou for their support!

We had some intense brainstorming and active discussions on research topics and problems in #prostatecancer at Apollo meeting by @IpsenGroup👍 It was priceless to learn the personal stories of our mentors and to get an expert advice on our ongoing projects. Thank you!🙌

After several years immersed in clinic and teaching, the Apollo project has been an incredible encounter to start improving my research skills. It is an honor to have met my mentor @joniau and the rest of the faculty. Long live the Apollo project and thanks to @IpsenGroup

Ready for a very interesting day in Athens on how to progress with prostate cancer research! A big thanks to the Apollo-program!

@Markuseckstein3 @DGUrologie @niklas_kluemper Great achievement @niklas_kluemper ! Welcome to the club 😉

Winning the Maximilian Nitze Price of the @DGUrologie #DGU24 is the most important scientific award in academic urology and urooncology in Germany. @niklas_kluemper made it 🎉🍾!!! Well deserved for your hard and dedicated work for advancing medical care for urlthelial cancer patients ! @OncoAlert @urotoday @Uroweb @imedverse @amerseburger @niklas_kluemper

Honored to share the 🇺🇾🇦🇷experience with #PaclitaxelDextranCoatedBalloon for Post Operative Ureteral Strictures during #WCET24 🇰🇷 #SEOUL BS1:15 📁 #JavierZeballos @SauUrologia @ResidentesCAU @ResidentesCAU @Endo_Society @luisrico89 @AlexRuebben @AmerUrological @Uroweb @UrowebESU

⚠️⚠️⚠️Publication alert!⚠️⚠️⚠️ nature.com/articles/s4155… Congratulations #BrabletzLab and @KoeberleLab for this amazing study. Happy to have played a tiny role #ferroptosis #lipidmetabolism #cancerplasticity

Great to have @tompowles1 at #UroTrials in Düsseldorf. Prediction: 80% less cystectomies in the next five years given recent advances in the field. So rCx only in case of local complications/bleeding in the future? @amerseburger @JimCatto @daviesbj @uretericbud

📌 Prostate cancer ⏩ Phase Ib trial -Tarlatamab Tarlatamab showed manageable safety profile in Neuroendocrine #Prostate #Cancer, showing antitumor activity on DLL3 expression. #ASCO24 @OncoAlert

@MSLee_MD @quanta_system 💪 Try it out and let me know how it works for you!

@chariskalogirou @quanta_system Yeah that’s awesome. I do this to very stubborn beach balls with the perc n circ but didn’t know this bag existed!

Bloodless R0 en-bloc TURBT for solitary pT2a #bladdercancer with @quanta_system #virtualbasket mode. Smooth resection surface, specimen retrieval with bag, 30min OR time. Are there any arguments left for classic TURBT? #urosome #urology #lasers #endoscopy

Exciting advances in prostate cancer treatment at #ASCO24! ⚪️ JNJ-6420, a novel anti-hK2 Ab-based targeted #radiotherapy, shows promising results in heavily pretreated mCRPC patients. ⚪️ Despite notable adverse events, profound and durable responses were observed at ≥150 μCi doses. @ASCO @OncoAlert

@MSLee_MD @quanta_system Check this tweet from last year for the bag specifications (in comments) - you advance the bag through the nephroscope and extract the specimen a bit like a stone with a basket in semirigid ureteroscopy 😉 x.com/chariskalogiro…

@chariskalogirou @quanta_system How did you retrieve with specimen bag? through urethra? Nice video!

@JnsHerrmann @quanta_system This is a good one! Depends on patients preference. If it is a „single tumor in time and space“ I would go for bladder preservation, ph with triple-T. If a definite solution is warranted - robotic cx + neobladder.

@chariskalogirou @quanta_system Nice Job Charis. What are you going to do next with this Patient? Guidelines are not prepared for these cases IMO.

@MSLee_MD @quanta_system Slow and steady through the urethra. Depends on tumor stiffness - good question though, sometimes it’s really fiddely. If the specimen is too big, I usually cut in in half with the laser and retrieve it in 2 pieces.